Tirzepatide received FDA approval as Mounjaro (type 2 diabetes) in May 2023 and as Zepbound (obesity) in November 2023
Semaglutide & Medical Weight Loss FAQs Is semaglutide FDA-approved
[4] [12] It is currently being evaluated in Phase III clinical trials, most notably the TRIUMPH programme conducted by Eli Lilly and Company
This raises valid concerns about ingredient consistency and long-term results, especially when compared to name-brand options
77,78 However, the results of blinded studies have not been as promising
Noom Med Pricing: $42.25/month membership + medication costs (not included) Medications Offered: Ozempic, Wegovy, Mounjaro, Zepbound Program Features: Psychology-based behavior modification program Daily education lessons Color-coded food tracking system One-on-one health coaching Support groups Insurance: Some insurance companies cover Noom programs and GLP-1 prescriptions through Noom Best For: People interested in addressing the psychological aspects of weight loss alongside medication